NNVC - NanoViricides, Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NNVC - NanoViricides, Inc.

NNVC 1.110

-0.9%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: drkaz who wrote (3208)	12/8/2014 11:36:05 PM
From: drkaz	Read Replies (1) of 12873

Dr. Seymour's response to my message: Makes sense - as the Dengucide animal testing work that would have been used to support the application would have been done in Dr. Harris's lab,.... I remain inclined to dismiss the message and it's source. --------------------------------------- Are you kidding? Monday, December 8, 2014 11:07 PM Mark as Unread Flag this message From: "eugeneseymourmd@mac.com" <eugeneseymourmd@mac.com> To: "Me" <xxxxxxxx@yahoo.com> Full Headers Printable View Remember, we do none of our own animal work. All we do is prepare the drug samples and ship them to the research facility The dengue work was done by Dr. Eva Harris, Professor of Infectious Diseases at UCBerkeley, winner of the MacArthur genius grant and an acknowledged world expert on dengue/dengue hemorrhagic fever. To suggest that she would falsify data is a serious charge More lies with no substance and no facts Please feel free to post my response Eugene Seymour MD MPH Chief Executive Officer NanoViricides, Inc eugene@nanoviricides.com www.nanoviricides.com 310-486-5677 "NNVC" on the New York Stock Exchange

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next